OBIOOrchestra BioMed Holdings, Inc.
$5.73+110% 1Y
$5.73
$2.8752 weeks$6.36
Is the price fair?
What OBIO's price assumes
Orchestra BioMed Holdings, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 7.78× revenue.
7.78
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 6.18
Price / book · as of 2026-Q1
- EV / sales
- 7.39
EV / sales
Details›
- Price / bookas of 2026-Q1
- 6.18
- EV / EBIToperating margin −181%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 7.39
- Market capitalisation
- $343M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.